Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METabolic EXplorer Earnings Release 2010

Nov 4, 2010

1519_iss_2010-11-04_5acb9740-6e0a-402b-a02e-46a2055ee693.pdf

Earnings Release

Open in viewer

Opens in your device viewer

METabolic EXplorer: Update on third-quarter 2010 activity

Clermont-Ferrand, France, 4 November 2010 – METabolic Explorer, a green chemistry company that specializes in the development of bioprocesses for the production of chemical compounds used in a wide range of everyday products (textile fibres, paints, solvents, animal feed supplements, adhesives, etc.), today updated investors on its third-quarter 2010 activity.

The vagaries of the calendar have caused to company to disclose details of its third-quarter activity today, Thursday November 4th, 2010.

METabolic EXplorer would remind editors that a press conference, announced on Tuesday November 2nd, has been called for tomorrow, Friday November 5th, to provide a complete overview of company activity and in particular of its latest commercial developments (attendance at the press conference is restricted to journalists, financial analysts and institutional investors).

The present press release therefore only contains details of important financial data for the third quarter of 2010.

Q3: Main financial data

Turnover for the period

(€ 000s) 2010 2009
st quarter
1
0 0
nd quarter
2
0 900
rd quarter
3
600 0
9-month turnover 600 900

Over the first three quarters of the 2010 accounting period, METabolic EXplorer recorded turnover of €600,000. This was generated by licence income from two processes (Glycolic Acid and L-Methionine) developed under a partnership agreement. The contract income is paid on achieving agreed project targets and as such may vary considerably from one quarter to another.

Cash and Equivalent

As at September 30th, 2010 the company had gross cash and equivalent of €40.2 million.

-END-

About METabolic EXplorer - www.metabolic-explorer.com

METabolic EXplorer is a biological chemistry company which was incorporated in 1999. Its goal is to help industrial businesses deal with the heralded "end of oil", so that they can continue to manufacture but in a sustainable way.

Based on the tried and tested principle of industrial fermentation, METabolic Explorer's solutions circumvent the problems posed by today's burdensome and expensive petrochemical processes via the use of a wide range of renewable, sustainable raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, paints, solvents, plastics and animal feed).

METabolic EXplorer is currently focusing its alternative biological solutions on the production of five compounds that together have an estimated, annual, end-market value of €11 billion. The company's strategy will be implemented in two ways: either through the creation of manufacturing plants in strategic geographic locations, or via limited-exclusivity industrial partnerships as part of joint-ventures.

METabolic Explorer, based in Clermont-Ferrand, France, is listed on EURONEXT PARIS (EURONEXT C, METEX) and features in the SBF 250 and CAC Small 90 indexes.

Get free financial information on METabolic EXplorer by registering with www.metabolic-explorer.com or www.actus-finance.com.

Media and shareholder contacts

ATTITUDE Corporate Eric de Lambert E-mail: [email protected] Tel.: +33 (0)1 4970 4341 / +33 (0)6 2529 0658

Emmanuelle Lapeyre E-mail: [email protected] Tel.: +33 (0)1 4970 4343 / +33 (0)6 1588 6209

Investor and analyst contacts

Actus Finance Jérôme Fabreguettes-Leib Email: [email protected] Tel.: +33 (0)1 7735 0436

This communication includes forward-looking information which is subject to risks and uncertainties. The potential development of the company could be substantially different from that anticipated in this press release because of the various risk factors which are described in the company's Listing Prospectus.